U.S. HMC Series Fund LP - Series VIII reports $100,000 sold in an exempt offering with a $13,250,000 offering amount. Investors can see the fund’s Venture Capital classification, Rule 506(b) and 3(c)(1) structure, indefinite offering duration and $15,000 expense allocation in the reported terms.

Key Highlights

  • The exempt offering carries a stated amount of $13,250,000 ($13.3 million).
  • The fund identifies Rule 506(b), Rule 3(c) and Rule 3(c)(1) within its offering structure.
  • Ten investors are reported, while $15,000 is allocated to organizational and operating expenses.

U.S. HMC Series Fund LP - Series VIII reports $100,000 in sales from an exempt offering. The offering is listed with an indefinite duration.

$13.25 Million Offering Structure

The offering records $13,250,000 ($13.3 million) as its stated offering amount. U.S. HMC Series Fund LP - Series VIII identifies Rule 506(b), Rule 3(c) and Rule 3(c)(1) in the offering structure. Ten investors are reported under the offering. A $15,000 amount is designated for fund organizational and operating expenses. The fund is organized in Delaware as a Limited Liability company. US HMC Series GP LLC is identified as an executive officer.

Venture Capital Fund Names Managing Member

The fund is classified as a venture capital fund. George G. Chen is named managing member of U.S. HMC Series Fund LP - Series VIII. The reported date is September 1, 2026. The same address is listed for US HMC Series GP LLC.